A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative

Health Technol Assess. 2003;7(4):iii-62. doi: 10.3310/hta7040.

Authors

J Chilcott¹, M Lloyd Jones, J Wight, K Forman, J Wray, C Beverley, P Tappenden

Affiliation

¹ School of Health and Related Research, University of Sheffield, UK.

PMID: 12633527
DOI: 10.3310/hta7040

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Cost-Benefit Analysis
Erythroblastosis, Fetal / economics
Erythroblastosis, Fetal / immunology
Erythroblastosis, Fetal / prevention & control*
Female
Humans
Isoantibodies / immunology
Pregnancy
Pregnancy Complications, Hematologic / economics
Pregnancy Complications, Hematologic / prevention & control*
Rh-Hr Blood-Group System / immunology
Rho(D) Immune Globulin / economics*
Rho(D) Immune Globulin / therapeutic use*
United Kingdom

Substances

Isoantibodies
RHO(D) antibody
Rh-Hr Blood-Group System
Rho(D) Immune Globulin